Piperazine substituted carboxylic acid derivatives for treating hyperlipimia
US5532371A · kind A · utility
17Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 1995 |
| Grant date | Jul 2, 1996 |
| Priority date | — |
| Expiry date | Jan 25, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
An arylamide derivative of formula (1), a salt thereof and a therapeutic agent for hyperlipemia which comprises the derivative or salt: ##STR1## wherein Ar represents a group ##STR2## a naphthyl group, a pyridinyl group, a furyl group, a thienyl group, a quinolyl group or an indolyl group; Y represents a group ##STR3## and Q represents --O-- or a single bond, Z represents an alkylene group, and R.sup.4 represents a hydroxyl group, an alkoxy group or a group --NH(CH.sub.2).sub.m COOH.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.